No Data
12 Health Care Stocks Moving In Friday's Pre-Market Session
Needham Maintains Esperion Therapeutics(ESPR.US) With Buy Rating, Maintains Target Price $6
Esperion Therapeutics Price Target Maintained With a $6.00/Share by Needham
Express News | Esperion Enters Privately Negotiated Exchange And Subscription Agreements With Certain Holders Of 4.00% Convertible Senior Subordinated Notes Due 2025
Esperion Announces $210M Convertible Debt Financing
Press Release: Esperion Announces $210 Million Convertible Debt Financing
No Data
Youngman : Hang in there guys
Drassasin : I hope this stock can make us all wealthy.
74480569 : Why do we have to pay 5.75% interest when the interest rate has been lowered?
AB84 OP 74480569 : Risk
74480569 : This dish is too scary.
View more comments...